Finance

Lists
CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$2.66
-1.85%
(-0.050) 1D
$2.68
+0.56% (+0.015)
After hours
Closed: Oct 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CATX...
Open
$2.71
High
$2.76
Low
$2.62
Mkt. cap
303.64M
Avg. vol.
2.14M
Volume
1.10M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
Open
$2.71
High
$2.76
Low
$2.62
Mkt. cap
303.64M
Avg. vol.
2.14M
Volume
1.10M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
News stories
From web sources and news partners
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteperspectivetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
209.00K
43.00K
76.00K
81.00K
Cost of goods sold
20.34M
32.92M
21.37M
21.54M
Cost of revenue
20.34M
32.92M
21.37M
21.54M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.73M
6.95M
6.98M
7.80M
Operating expense
7.73M
6.95M
6.98M
7.80M
Total operating expenses
28.07M
39.88M
28.36M
29.34M
Operating income
-27.86M
-39.83M
-28.28M
-29.26M
Other non operating income
-
-
-
-
EBT including unusual items
-25.97M
-38.28M
-26.19M
-26.98M
EBT excluding unusual items
-25.97M
-38.28M
-26.19M
-26.98M
Income tax expense
-
-793.00K
-
-
Effective tax rate
-
2.07%
-
-
Other operating expenses
-
-
-
-
Net income
-25.97M
-37.49M
-26.19M
-26.79M
Net profit margin
-12,425.36%
-87,186.05%
-34,459.21%
-33,069.14%
Earnings per share
-0.35
-0.51
-0.25
-0.22
Interest and investment income
1.96M
1.61M
2.20M
2.35M
Interest expense
-65.00K
-64.00K
-105.00K
-71.00K
Net interest expenses
1.89M
1.55M
2.09M
2.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.09M
-38.83M
-27.16M
-28.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps